Source: BioSpace

Tarix Orphan: <b>Tarix Orphan</b> Granted Orphan Drug Status For TXA127 As Potential Treatment For Congenital Muscular Dystrophy (MDC1A)

Life Sciences Jobs ...

Read full article »
Tarix Orphan's Competitors | Tarix Orphan's News | Tarix Orphan's Financials
Stay up-to-date with the latest news on Tarix Orphan
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

President & CEO

Richard Franklin

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Tarix Orphan